- Home
- AII vs ZVRA Comparison
AII vs ZVRA Comparison
Compare AII & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AII
- ZVRA
- Stock Information
- Founded
- AII 2006
- ZVRA 2006
- Country
- AII United States
- ZVRA United States
- Employees
- AII N/A
- ZVRA N/A
- Industry
- AII Property-Casualty Insurers
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- AII Finance
- ZVRA Health Care
- Exchange
- AII Nasdaq
- ZVRA Nasdaq
- Market Cap
- AII 488.5M
- ZVRA 499.9M
- IPO Year
- AII 2025
- ZVRA 2015
- Fundamental
- Price
- AII $24.22
- ZVRA $9.14
- Analyst Decision
- AII Buy
- ZVRA Strong Buy
- Analyst Count
- AII 6
- ZVRA 7
- Target Price
- AII $26.20
- ZVRA $21.71
- AVG Volume (30 Days)
- AII 97.7K
- ZVRA 1.5M
- Earning Date
- AII 11-11-2025
- ZVRA 11-05-2025
- Dividend Yield
- AII N/A
- ZVRA N/A
- EPS Growth
- AII N/A
- ZVRA N/A
- EPS
- AII 4.32
- ZVRA 0.54
- Revenue
- AII $275,530,000.00
- ZVRA $84,388,000.00
- Revenue This Year
- AII $25.82
- ZVRA $336.43
- Revenue Next Year
- AII $25.65
- ZVRA $54.26
- P/E Ratio
- AII $5.58
- ZVRA $16.99
- Revenue Growth
- AII 37.17
- ZVRA 244.60
- 52 Week Low
- AII $15.78
- ZVRA $6.19
- 52 Week High
- AII $26.36
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- AII N/A
- ZVRA 42.38
- Support Level
- AII N/A
- ZVRA $8.51
- Resistance Level
- AII N/A
- ZVRA $9.69
- Average True Range (ATR)
- AII 0.00
- ZVRA 0.60
- MACD
- AII 0.00
- ZVRA -0.13
- Stochastic Oscillator
- AII 0.00
- ZVRA 25.86
About AII American Integrity Insurance Group Inc. Common Stock
American Integrity Insurance Group Inc is engaged in the property and casualty insurance business. It provides personal residential property insurance for single-family homeowners and condominium owners as well as coverage for vacant dwellings and investment properties, predominantly in Florida. The Company's property and casualty insurance is currently offered in Florida, South Carolina, and Georgia.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.